Hennessy Advisors Inc’s Phibro Animal Health PAHC Stock Holding History

Hennessy Advisors Inc’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.96M	Buy	+221,700	New	+$9.35M	0.22%	131

Other funds holding PAHC

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Hennessy Advisors Inc's PAHC Position: Q2 2026 in Review

Hennessy Advisors Inc opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 221,700 shares worth $6.96M. The stake represents 0.22% of the portfolio and ranks #131 among its holdings.

12 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Hennessy Advisors Inc held 221,700 shares of Phibro Animal Health worth $6.96M as of Q2 2026.
Phibro Animal Health was a new Hennessy Advisors Inc position in Q2 2026.
Phibro Animal Health made up 0.22% of Hennessy Advisors Inc's portfolio in Q2 2026, its #131 holding.
12 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Hennessy Advisors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.